Illumina continues to focus on transforming human health practices through its leadership of genomic sequencing and related applications. The firm provides a broad range of instruments and related ...

Illumina Inc. (NASDAQ:ILMN), a leading provider of next-generation sequencing (NGS ... and marketing life science tools and integrated systems for genetic analysis. The company’s core business ...

Illumina, Inc. (NASDAQ: ILMN), a global leader in DNA sequencing and array-based technologies, has been named for the sixth ...

"Africa CDC is pleased to continue its collaboration with Illumina and other partners to enhance ... and this collaboration will help integrate next-generation sequencing into routine public health ...

BOSTON - Volta Labs, a genomics applications company, has integrated its Callisto™ Sample Prep System into Ginkgo Bioworks' Illumina (NASDAQ:ILMN) sequencing workflow, aiming to streamline and ...

Kokoris came up with the idea of solving some of the noise issue of nanopore sequencing by converting DNA into larger ...

Illumina has long dominated the next-generation sequencing and clinical markets and another – potentially superior – high-throughput system on the horizon could put planned purchases on hold.

Just days before the AGBT meeting kicks off in Marco Island, FL, the company hosted a much-anticipated webinar to offer a technical introduction to their sequencing expansion technology (SBX): a ...

With healthcare systems under pressure to improve patient outcomes while managing costs, the integration of whole genome sequencing (WGS ... As technology advances, Swaroop Aradhya, Illumina's global ...